A D-peptide ligand of nicotine acetylcholine receptors for brain-targeted drug delivery (Q48370390)

11 February 2018

title

A D-peptide ligand of nicotine acetylcholine receptors for brain-targeted drug delivery (English)

1 reference

11 February 2018

1 reference

Xiaoli Wei

1

1 reference

11 February 2018

Changyou Zhan

2

1 reference

11 February 2018

Qing Shen

3

1 reference

11 February 2018

Wei Fu

4

1 reference

11 February 2018

Cao Xie

5

1 reference

11 February 2018

Jie Gao

6

1 reference

11 February 2018

Chunmei Peng

7

1 reference

11 February 2018

Ping Zheng

8

1 reference

11 February 2018

Weiyue Lu

9

1 reference

11 February 2018

language of work or name

English

0 references

publication date

19 January 2015

1 reference

11 February 2018

Angewandte Chemie International Edition

published in

0 references

volume

54

1 reference

11 February 2018

issue

10

1 reference

11 February 2018

page(s)

3023-3027

1 reference

11 February 2018

Molecular Trojan horses for blood-brain barrier drug delivery

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

Transvascular delivery of small interfering RNA to the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

Loop 2 of Ophiophagus hannah toxin b binds with neuronal nicotinic acetylcholine receptors and enhances intracranial drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

Identification and design of peptides as a new drug delivery system for the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

Retro-inverso isomer of Angiopep-2: a stable d-peptide ligand inspires brain-targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

Nicotinic Acetylcholine Receptors of Muscles and Nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

Nicotine and cotinine modulate cerebral microvascular permeability and protein expression of ZO-1 through nicotinic acetylcholine receptors expressed on brain endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

Neuronal nicotinic receptors: from structure to pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

Nicotinic acetylcholine receptors: from structure to brain function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

Crystal structure of a Cbtx-AChBP complex reveals essential interactions between snake alpha-neurotoxins and nicotinic receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

Crystal structure of nicotinic acetylcholine receptor homolog AChBP in complex with an alpha-conotoxin PnIA variant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

ATP is required for receptor-mediated endocytosis in intact cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

Drug delivery systems: entering the mainstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

Nicotinic acetylcholine receptor is internalized via a Rac-dependent, dynamin-independent endocytic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

Delivery of peptides and proteins through the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

The blood-brain/tumor barriers: challenges and chances for malignant gliomas targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

Cyclic RGD-polyethylene glycol-polyethylenimine for intracranial glioblastoma-targeted gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

Drug transport across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

Transport of [125I]transferrin through the rat blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANIE.201411226

21 January 2018

Identifiers

DOI

10.1002/ANIE.201411226

1 reference

11 February 2018

1 reference

11 February 2018